NCT01859858View on ClinicalTrials.gov

Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

October 5, 2016

Study Completion Date

October 5, 2016

Conditions
Advanced Colorectal Cancer
Interventions
DIETARY_SUPPLEMENT

curcumin

DRUG

Irinotecan

Trial Locations (2)

27509

University of North Carolina at Chapel Hill Lineberger Comprehensive cancer Center, Chapel Hill

46202

IU Simon Cancer Center, Indianapolis

All Listed Sponsors
lead

UNC Lineberger Comprehensive Cancer Center

OTHER

NCT01859858 - Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors | Biotech Hunter | Biotech Hunter